Azelaic acid 20% cream in the treatment of facial hyperpigmentation in darker-skinned patients

Clinical Therapeutics

Volumn 20, Issue 5, 1998, Pages 945-959

  Lowe, Nicholas J ^a,b,e   Rizk, Dalia ^a,b   Grimes, Pearl ^c   Billips, Mavis ^c   Pincus, Stephanie ^d  

^a Clinical Research Specialists   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Vitiligo Pigmentation Inst S C   (United States)

^d UNIVERSITY AT BUFFALO   (United States)

^e NONE   (United States)

Author keywords

Azelaic acid; Darker skin; Hyperpigmentation; Melasma

Indexed keywords

AZELAIC ACID; CORTICOSTEROID; HYDROQUINONE; RETINOID; SUNSCREEN;

ADULT; ARTICLE; CHLOASMA; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CREAM; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; FEMALE; HUMAN; HYPERPIGMENTATION; MAJOR CLINICAL STUDY; MALE; PRURITUS; RANDOMIZED CONTROLLED TRIAL; SKIN IRRITATION; SKIN PIGMENTATION; STATISTICAL ANALYSIS; TREATMENT OUTCOME;

EID: 0031758932     PISSN: 01492918     EISSN: 1879114X     Source Type: Journal    
DOI: 10.1016/S0149-2918(98)80076-3     Document Type: Article

References (25)

1. Grimes PE. Melasma. Etiologic and therapeutic considerations. Arch Dermatol. 1995;131:1453-1457.
2. Frenk E. Treatment of melasma with depigmenting agents. In: Melasma: New Approaches to Treatment. London: Martin Dunitz Ltd.; 1995:9-15.
3. Breathnach AC, Nazzaro-Porro M, Passi S, Zina G. Azelaic acid therapy in disorders of pigmentation. Clin Dermatol. 1989;7:106-119.
4. Fitton A, Goa KL. Azelaic acid. A review of its pharmacological properties and therapeutic efficacy in acne and hyperpigmentary skin disorders. Drugs. 1991;41: 780-798.
5. Nguyen QH, Bui TP. Azelaic acid: Pharmacokinetic and pharmacodynamic properties and its therapeutic role in hyperpigmentary disorders and acne. Int J Dermatol. 1995;34:75-84.
6. Graupe K, Cunliffe WJ, Gollnick HPM, Zaumseil R-P. Efficacy and safety of topical azelaic acid (20 percent cream): An overview of results from European clinical trials and experimental reports. Cutis. 1996;57(Suppl 1):20-35.
7. Balina LM, Graupe K. The treatment of melasma. 20% azelaic acid versus 4% hydroquinone cream. Int J Dermatol. 1991; 30:893-895.
8. Gibson JR. Rationale for the development of new topical treatments for acne vulgaris. Cutis. 1996;57(Suppl 1):13-19.
9. Fitzpatrick TB. The validity and practicality of sunreactive skin types I through VI. Arch Dermatol. 1988;124:869-871.
10. Fitzpatrick TB. Pathophysiology of hypermelanosis. Clin Drug Invest. 1995;10 (Suppl 2):17-26.
11. Seitz JC, Whitmore CG. Measurement of erythema and tanning responses in human skin using a tri-stimulus colorimeter. Dermatologica. 1988;177:70-75.
12. Andreassi L, Casini L, Simoni S, et al. Measurement of cutaneous colour and assessment of skin type. Photodermatol Photoimmunol Photomed. 1990;7:20-24.
13. Berry D. Statistical Methodology in the Pharmaceutical Sciences. New York: Marcel Dekker; 1990:464-465.
14. Cox DR, Oakes D. Analysis of Survival Data. London: Chapman & Hall; 1984.
15. Colton T. Statistics in Medicine. Boston: Little Brown and Co.; 1974:176.
16. Peace KL. Biopharmaceutical Statistics for Drug Development. New York: Marcel Dekker; 1988.
17. Conover W. Practical Nonparametric Statistics. 2nd ed. New York: John Wiley and Sons; 1980:216-218.
18. Verallo-Rowell VM, Verallo V, Graupe K, et al. Double-blind comparison of azelaic acid and hydroquinone in the treatment of melasma. Acta Derm-Venereol Suppl (Stockh). 1989;143:58-61.
19. Cunliffe WJ, Holland KT. Clinical and laboratory studies on treatment with 20% azelaic acid cream for acne. Acta Derm-Venereol Suppl (Stockh). 1989;143:31-34.
20. Katsambas A, Graupe K, Stratigos J. Clinical studies of 20% azelaic acid cream in the treatment of acne vulgaris: Comparison with vehicle and topical tretinoin. Acta Derm-Venereol Suppl (Stockh). 1989; 143:35-39.
21. Cavicchini S, Caputo R. Long-term treatment of acne with 20% azelaic acid cream. Acta Derm-Venereol Suppl (Stockh). 1989; 143:40-44.
22. Carmichael AJ, Marks R, Graupe KA, Zaumseil RP. Topical azelaic acid in the treatment of rosacea. J Dermatol Treat. 1993;4(Suppl 1):19-22.
23. Breathnach AS. Pharmacological properties of azelaic acid. A rationale for clinical use. Clin Drug Invest. 1995;10(Suppl 2):27-33.
24. Akamatsu H, Komura J, Asada Y, et al. Inhibitory effect of azelaic acid on neutrophil functions: A possible cause for its efficacy in treating pathogenetically unrelated disorders. Arch Dermatol Res. 1991; 283:162-166.
25. Zaumseil R-P, Graupe K. Topical azelaic acid in the treatment of melasma: Pharmacological and clinical considerations. In: Melasma: New Approaches to Treatment. London: Martin Dunitz Ltd.; 1995: 16-40.